Free Trial
→ Trump’s Plan To Cheat History (From Porter & Company) (Ad)tc pixel
OTCMKTS:OTSKY

Otsuka Q2 2026 Earnings Results & Report

Otsuka logo
$38.64 +0.50 (+1.32%)
As of 03:53 PM Eastern

Otsuka beat analyst expectations on both earnings and revenue in its Q2 2026 results, released July 31, 2026. The company reported EPS of $0.70 versus the $0.5060 consensus estimate, while revenue of $4.41 billion topped the $3.95 billion estimate by $458.86 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Otsuka EPS Results

Actual EPS
$0.70
Consensus EPS
$0.5060
Beat/Miss
Beat by +$0.1940
One Year Ago EPS
N/A

Otsuka Revenue Results

Actual Revenue
$4.41 billion
Expected Revenue
$3.95 billion
Beat/Miss
Beat by +$458.86 million
YoY Revenue Growth
N/A

Upcoming Earnings

Otsuka's next earnings date is estimated for Friday, October 30, 2026, based on past reporting schedules.

Conference Call Resources

Otsuka Q2 2026 Earnings FAQ

Otsuka (OTCMKTS:OTSKY) reported earnings of $0.70 per share for Q2 2026, beating the consensus estimate of $0.5060. The report was announced on Friday, July 31, 2026.

Otsuka reported revenue of $4.41 billion for Q2 2026, against a consensus estimate of $3.95 billion.

Otsuka's next earnings date is estimated for Friday, October 30, 2026. MarketBeat tracks confirmed and estimated earnings dates for Otsuka on the company's earnings history page.

Otsuka Earnings Headlines

Otsuka (OTCMKTS:OTSKY) Shares Gap Down - Here's Why
October 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31111207
Dr. Reddy's Laboratories (NYSE:RDY) & Otsuka (OTCMKTS:OTSKY) Head to Head Review
October 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31099018
Did you grab your copy yet?
Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarter he swaps in a brand-new list, and once the new edition launches, this one disappears. Investors who want a current snapshot of his picks should grab a copy now and save it before the switch happens.tc pixel
October 16 at 1:00 AM  |  Profits Run (Ad)
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931746-otsuka-holdings-co-ltd-otsky-discusses-24-month-egfr-results-of-sibeprenlimab-in-iga
Otsuka Holdings Co (OTSKF) Gets a Buy from Bank of America Securities
July 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OTSKY/pressreleases/3445304/otsuka-holdings-co-otskf-gets-a-buy-from-bank-of-america-securities/
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Otsuka Holdings Co (OTSKY)
July 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OTSKY/pressreleases/3429352/analysts-are-bullish-on-these-healthcare-stocks-arrowhead-pharmaceuticals-arwr-otsuka-holdings-co-otsky/
See More Otsuka Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Otsuka? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Otsuka and other key companies, straight to your email.

About Otsuka

Otsuka (OTCMKTS:OTSKY) Holdings Co., Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co., Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields. Its nutraceutical and consumer health businesses offer products designed to support hydration, nutrition and general wellness, including the Pocari Sweat and Oronamin C brands in select markets. The group also has activities in medical devices and other health-related businesses.

Otsuka Holdings was established in 2008 as the holding company for the Otsuka Group and was listed on the Tokyo Stock Exchange in 2010. The group serves customers in Japan and international markets through research, manufacturing and commercial operations across North America, Europe, Asia and other regions. Tatsuo Higuchi serves as president and chief executive officer of Otsuka Holdings.

View Otsuka Profile
Earnings Tools